ISRCTN14538421

Monitoring blood sugar in patients with diabetes before and after cardiac surgery

Name: Clinical Trial ISRCTN14538421
Creator: St Vincent's Hospital
Keywords: Diabetes mellitus, Abbott FreeStyle Libre Pro Flash Glucose Monitoring System®, Phase 3/4, device, clinical trial, Australia

A prospective exploratory study of perioperative continuous glucose monitoring in adult patients with diabetes undergoing cardiac surgery

St Vincent's HospitalPhase 3/4ISRCTN RegistrydeviceDevice trial

VerifiedISRCTN Registry

Study focus

Disease/Condition: Diabetes mellitus
Drug/Device/Intervention: Abbott FreeStyle Libre Pro Flash Glucose Monitoring System®
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: St Vincent's Hospital
Location: Australia

Timeline & enrollment

Phase: Phase 3/4
Start date: Feb 01, 2021
End date: Mar 31, 2023
Enrollment: 30 participants

Summary

This study aims to investigate continuous glucose monitoring (CGM) metrics’ association with perioperative dysglycaemia and perioperative complications in patients with insulin-dependent diabetes undergoing elective cardiac surgery. The current pilot study aims to establish feasibility for a larger study in the future. The primary end points will be feasibility parameters, including the number of eligible patients at each study site, the consent rate, and the rate of patients successfully completing the study.

ICD-10 classifications

Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications

Data source

Registry: ISRCTN Registry
Trial ID: ISRCTN14538421
Type: Device Trial

About this record

Access comprehensive clinical trial information for ISRCTN14538421 through Pure Global AI's free database. This Phase 3/4 trial is sponsored by St Vincent's Hospital and is currently status unknown. The study focuses on Diabetes mellitus. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.